Nantahala Capital Management »

Evoke Pharma shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Evoke Pharma (EVOK) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Evoke Pharma

Tip: Access up to 7 years of quarterly data

All positions including Evoke Pharma held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evoke Pharma by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $412k 675k 0.61

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr Ser Tr S&p Biotech (XBI)
Establishment Labs Holdings Ord (ESTA)
Soleno Therapeutics (SLNO)
Eli Lilly & Co. Put Option (LLY)
Grand Canyon Education Put Option (LOPE)
Meta Financial (CASH)
Costco Wholesale Corporation Put Option (COST)
Evolus (EOLS)
Peloton Interactive Cl A Com (PTON)
Imax Corp Cad (IMAX)
Hilton Grand Vacations (HGV)
Bioventus Com Cl A (BVS)
Rumbleon Com Cl B (RMBL)
Ishares Tr U.s. Real Es Etf Put Option (IYR)

View all positions for Nantahala Capital Management

Top funds holding Evoke Pharma

AIGH Capital Management
Altium Capital Management
Nantahala Capital Management
Vanguard Group
Geode Capital Management
Goldman Sachs Group
Millennium Management
Tower Research Capital
BlackRock
UBS Group
Morgan Stanley
Goss Wealth Management
Wells Fargo & Company
Royal Bank of Canada

View all funds holding Evoke Pharma